基于网络药理学和实验验证探讨白头翁汤干预结肠炎相关结直肠癌的作用机制

Mechanism of Baitouweng Decoction in the Treatment of Colitis-Associated Colorectal Cancer:A Study Based on Network Pharmacology and Experimental Verification

  • 摘要:
    目的 探索白头翁汤干预结肠炎相关结直肠癌的药效物质基础与作用机制,并通过体外实验进行初步验证。
    方法 通过TCMSP、中国中药整合数据库(TCMID)、中医药整合药理学研究平台(TCMIP)数据库并结合文献挖掘,获取白头翁汤的有效成分;借助PharmMapper Server平台预测白头翁汤有效成分的作用靶点;结合GeneCards中结肠炎相关结直肠癌疾病靶点、DrugBank中结肠炎相关结直肠癌化疗药效分子作用靶点,验证白头翁汤作用靶点与结肠炎相关结直肠癌之间的关系;借助Cytoscape软件构建“中药-有效成分-靶点”“有效成分-靶点”网络模型;基于DAVID数据库分析白头翁汤干预结肠炎相关结直肠癌的作用通路,使用细胞增殖与活性检测-8(CCK8)法和流式细胞术检测白头翁汤处理过的结肠癌SW480细胞的增殖和凋亡情况,使用qRT-PCR检测炎症因子的表达情况,同时通过Western blot检测SW480细胞中EGFR和PI3K/AKT信号通路中关键蛋白的变化。
    结果 从白头翁汤干预结肠炎相关结直肠癌“有效成分-靶点”网络得到有效成分98个和靶点87个(其中核心有效成分12个,核心靶点11个);KEGG通路主要涉及癌症途径、前列腺癌、癌症蛋白多糖、PI3K-AKT信号通路、EGFR酪氨酸激酶抑制剂等。分子对接结果显示,柠檬苦素、坎得毒素A、秦皮苷等与HRAS、IGF1、MAP2K1、HSP90AA1有较好的结合能力,体外实验证实白头翁汤有效抑制SW480细胞增殖、促进细胞凋亡,同时下调靶点蛋白EGFR、p-AKT和p-PI3K的表达、有效抑制IL-6、IL-1β、TNF-α、iNOS的表达。
    结论 白头翁汤可通过介导EGFR及其下游信号通路,多层次、多途径地抑制结肠炎相关结直肠癌进展,促进肿瘤细胞凋亡。

     

    Abstract:
    OBJECTIVE To explore the pharmacodynamic material basis and mechanism of action of Baitouweng Decoction in the intervention of colitis-associated colorectal cancer (CAC), and to conduct preliminary verification through in vitro experiments. METHORDS Active ingredients of Baitouweng Decoction were identified using the TCMSP, Traditional Chinese Medicine Integrated Database (TCMID), and Integrative Pharmacology-based Research Platform of Traditional Chinese Medicine (TCMIP) database combined with literature mining. The PharmMapper Server platform was used to predict the targets of these active ingredients. The relationship between the targets of Baitouweng Decoction and CAC was verified by cross-referencing them with disease targets from GeneCards and drug targets associated with CAC chemotherapy from DrugBank. Network models of “Traditional Chinese Medicine-Active Ingredient-Target” and “Active Ingredient-Target” were constructed using Cytoscape software. Signaling pathways involved in the intervention of CAC by Baitouweng Decoction were analyzed using the DAVID database. The proliferation and apoptosis of SW480 colon cancer cells treated with Baitouweng Decoction were assessed using the CCK-8 assay and flow cytometry; the expression of inflammatory factors was measured via qRT-PCR; and changes in key proteins within the EGFR and PI3K/AKT signaling pathways in SW480 cells were detected by Western blot.
    RESULTS The “Active Ingredient-Target” network analysis identified 98 active ingredients and 87 targets (including 12 core active ingredients and 11 core targets). KEGG pathway analysis highlighted pathways related to cancer, prostate cancer, proteoglycans in cancer, the PI3K-AKT signaling pathway, and EGFR tyrosine kinase inhibitors. Molecular docking results demonstrated that compounds such as limonin, candletoxin A, and fraxin exhibited strong binding affinities with HRAS, IGF1, MAP2K1, and HSP90AA1. In vitro experiments confirmed that Baitouweng Decoction effectively inhibited the proliferation of SW480 cells and promoted apoptosis; simultaneously, it downregulated the expression of target proteins EGFR, p-AKT, and p-PI3K, and effectively suppressed the expression of IL-6, IL-1β, TNF-α, and iNOS.
    CONCLUSION Baitouweng Decoction inhibits the progression of colitis-associated colorectal cancer and promotes tumor cell apoptosis through a multi-level, multi-pathway mechanism involving the modulation of EGFR and its downstream signaling pathways.

     

/

返回文章
返回